Overview
Pituitary-dependent hypercortisolism, also known as Cushing's disease, is characterized by excessive cortisol production due to a pituitary adenoma secreting adrenocorticotropic hormone (ACTH). This leads to a spectrum of clinical manifestations including central obesity, hypertension, glucose intolerance, and osteoporosis 1.Diagnosis
Elevated midnight salivary or urinary free cortisol levels
Low-dose dexamethasone suppression test (DST) followed by high-dose DST showing inadequate suppression of cortisol
ACTH levels typically elevated or inappropriately normal
MRI of the pituitary gland to identify a tumor 1Management
First-line treatment: Surgical resection of the pituitary adenoma (transsphenoidal surgery) 1
Adjunctive treatments:
- Radiation therapy (e.g., stereotactic radiosurgery) for recurrent or persistent disease post-surgery 1
- Medical therapy:
- Dopamine agonists (e.g., cabergoline) for small tumors 1
- Mitotane or ketoconazole for adjunctive control of hypercortisolism 1Special Populations
Pregnancy: Management considerations include balancing maternal and fetal risks; close monitoring and multidisciplinary care are essential 1
Pediatrics: Limited evidence; tailored approaches focusing on growth and developmental impacts are crucial 1
Elderly: Increased risk of comorbidities; individualized treatment plans considering frailty and other health issues are recommended 1
Comorbidities: Management must address concurrent conditions such as hypertension and diabetes alongside hypercortisolism 1Key Recommendations
Confirm diagnosis using elevated cortisol levels and DST with MRI confirmation of pituitary adenoma 1 (Evidence: Strong)
Initiate with transsphenoidal surgery for pituitary adenoma resection 1 (Evidence: Strong)
Consider radiation therapy for cases refractory to surgery 1 (Evidence: Moderate)
Utilize medical management with dopamine agonists for smaller tumors or adjunctively for control 1 (Evidence: Moderate)
Tailor management in special populations, particularly emphasizing multidisciplinary care in pregnancy and pediatric cases 1 (Evidence: Expert opinion)References
1 Strauss L, Santti R, Saarinen N, Streng T, Joshi S, Mäkelä S. Dietary phytoestrogens and their role in hormonally dependent disease. Toxicology letters 1998. link00332-4)